NCT00389194View on ClinicalTrials.gov

PREventing Progression of Adipose Tissue Redistribution

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

October 31, 2008

Conditions
HIV Infections
Interventions
DRUG

continuing AZT+3TC or switching AZT+3TC to TDF+ FTC

Trial Locations (1)

Unknown

Academic Medical Centre, Amsterdam

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

International Antiviral Therapy Evaluation Center

OTHER